NCT06594588

Brief Summary

The goal of this project is to quantify the relative effectiveness of aerobic exercise monitored by smart wristbands in assisting the treatment of depression and improving cognitive function. It aims to explore the mechanisms through which aerobic exercise exerts its effects using imaging genetics and other methods, and to identify suitable populations for exercise, ultimately providing personalized clinical exercise prescriptions. This study will intervene from a behavioral perspective and also seeks to motivate participants to change and improve their physical activity habits.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 5, 2024

Completed
7 days until next milestone

Study Start

First participant enrolled

September 12, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

July 2, 2025

Status Verified

July 1, 2025

Enrollment Period

1.1 years

First QC Date

September 5, 2024

Last Update Submit

July 1, 2025

Conditions

Keywords

Aerobic exercise

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in Hamilton Depression Rating Scale (HAMD)

    The outcome is assessed by HAMD-17 Scale.

    Week 4 and 8 of treatment duration

Secondary Outcomes (15)

  • Change from baseline in THINC-it score

    Week 4 and 8 of treatment duration

  • Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS)

    Week 4 and 8 of treatment duration

  • Response to treatment

    Week 4 and 8 of treatment duration

  • Clinical Global Impression-Severity of Illness (CGI-S)

    Week 4 and 8 of treatment duration

  • Change from baseline in Hamilton Anxiety Rating Scale (HAMA)

    Week 4 and 8 of treatment duration

  • +10 more secondary outcomes

Study Arms (2)

Aerobic exercise group

EXPERIMENTAL

Aerobic exercise intervention combined with conventional drug treatment

Behavioral: Aerobic exercise

Waiting control group

NO INTERVENTION

Antidepressants were routinely used and aerobic exercise interventions were performed at the end of the 8-week follow-up

Interventions

Moderate-intensity aerobic exercise for 30-50 minutes three times a week was added to usual medical therapy

Aerobic exercise group

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Aged 18-45 years (including 18 and 45), no gender restriction;
  • Meets the diagnostic criteria for depressive disorders according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V);
  • Outpatients or inpatients; Hamilton Depression Rating Scale 17-item (HAMD-17) score ≥ 14; Mood Disorder Questionnaire (MDQ) screening negative to exclude bipolar disorder patients; and Clinical Global Impressions-Severity (CGI-S) score ≥ 4;
  • Maintained on antidepressant treatment for at least 4 weeks or not using antidepressant treatment;
  • Written informed consent obtained from the patient.

You may not qualify if:

  • Diagnosed with other mental disorders, including schizophrenia, bipolar disorder, alcohol or substance abuse/dependence, eating disorders, etc.;
  • Individuals with intellectual disabilities or who are unable to cooperate for other reasons, or those lacking or having incomplete civil capacity during the onset of illness;
  • Suffering from neurological or organic brain diseases (such as stroke, cerebral hemorrhage, brain tumors, Parkinson's disease, epilepsy, etc.) and a history of severe traumatic brain injury;
  • Suffering from conditions with high exercise risk, such as hypertension or heart disease;
  • Currently undergoing systematic psychological therapy;
  • In the 3-minute step test, males with a recovery heart rate more than131 and females with a recovery heart rate more than 140;
  • Physically restricted individuals unable to participate in physical exercise;
  • Physical Activity Readiness Questionnaire (PAR-Q) score ≥ 2;
  • Pregnant women or individuals with contraindications to MRI examinations;
  • Individuals with severe suicidal tendencies or at risk of harming others.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University Sixth Hostipal

Beijing, Beijing Municipality, 100191, China

RECRUITING

MeSH Terms

Interventions

Exercise

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Weihua Yue, Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 5, 2024

First Posted

September 19, 2024

Study Start

September 12, 2024

Primary Completion

October 30, 2025

Study Completion

December 30, 2025

Last Updated

July 2, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations